Click on image to view larger version.

Figure 1 Fully adjusted risk ratios are plotted for the end points of hospitalization for chronic obstructive pulmonary disease (COPD), myocardial infarction (MI), death, and MI or death. Treatments analyzed were angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), statins (hydroxymethylglutaryl CoA reductase inhibitors [HMG-CoA]), and the combination of statins with ACE inhibitors or ARBs (combination) in the population of COPD patients with prior revascularization (high risk). Results including steroid users are in the right panel.